Covaxin showed 81% interim efficacy: Bharat Biotech on Phase 3 results ...Middle East

The interim analysis was based on 43 recorded cases of Covid-19 in the trial of 25,800 participants

Hence then, the article about covaxin showed 81 interim efficacy bharat biotech on phase 3 results was published today ( Wednesday 03/03/2021 - 03:16 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Covaxin showed 81% interim efficacy: Bharat Biotech on Phase 3 results )

Also on site :

• Meta-backed Hupo finds growth after pivot to AI sales coaching from mental wellness
• TCL Dominates CES 2026 with Ultimate Display Innovation
• Iran protests latest: Trump to be briefed on military strike options after he orders new sanctions on Tehran